Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)
China flag China · Delayed Price · Currency is CNY
6.21
+0.01 (0.16%)
Feb 4, 2026, 10:25 AM CST

SHE:300039 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
778.83593.31601.94694.691,3451,307
Short-Term Investments
662.99924.87--58.3236.13
Trading Asset Securities
197.81180.02150.01136.0751.26114.65
Cash & Short-Term Investments
1,6401,698751.95830.761,4551,458
Cash Growth
23.89%125.84%-9.49%-42.88%-0.23%8.09%
Accounts Receivable
351.65471.99529.32530.33567.99528.76
Other Receivables
0.4234.5110.3435.7746.7732.32
Receivables
352.07506.51539.67566.09614.76562.39
Inventory
199.05187.85171.79160.8165.14191.54
Other Current Assets
39.9122.8111.4716.7719.998.08
Total Current Assets
2,2312,4151,4751,5742,2542,220
Property, Plant & Equipment
259.41267.85290.09304.66307.78295.87
Long-Term Investments
1,3901,6242,7301,312711.06280.24
Goodwill
---9.0413.7918.5
Other Intangible Assets
164.9168.845.1144.2342.945.26
Long-Term Deferred Tax Assets
26.4829.4431.6118.2615.117.55
Long-Term Deferred Charges
2.932.440.210.32--
Other Long-Term Assets
884.1711.037.64996.4910.75-
Total Assets
4,9584,5184,5804,2593,3562,877
Accounts Payable
104.9999.37134.8591.0175.0262.23
Accrued Expenses
4.7426.4623.2729.6915.9213.47
Short-Term Debt
4.175.42---35.72
Current Income Taxes Payable
38.1831.6241.0835.543.478.82
Current Unearned Revenue
13.8418.2945.6940.042.881.75
Other Current Liabilities
14.0851.1589.9699.6793.39115.56
Total Current Liabilities
180232.3334.85295.96190.68237.55
Long-Term Unearned Revenue
48.4348.0343.2639.5147.1651.53
Long-Term Deferred Tax Liabilities
184.13135.11168.71162.7773.069.88
Total Liabilities
412.55415.45546.82498.24310.9298.96
Common Stock
1,0461,0461,0461,0461,0461,046
Additional Paid-In Capital
8.628.628.628.628.628.62
Retained Earnings
2,4882,3232,0501,7851,5771,468
Comprehensive Income & Other
1,002724.5926.33921.98413.5355.68
Total Common Equity
4,5454,1024,0313,7623,0452,578
Minority Interest
0.60.971.64-0.72-0-
Shareholders' Equity
4,5464,1034,0333,7613,0452,578
Total Liabilities & Equity
4,9584,5184,5804,2593,3562,877
Total Debt
4.175.42---35.72
Net Cash (Debt)
1,6351,693751.95830.761,4551,422
Net Cash Growth
23.85%125.12%-9.49%-42.88%2.28%5.44%
Net Cash Per Share
1.561.620.720.791.391.36
Filing Date Shares Outstanding
1,0461,0461,0461,0461,0461,046
Total Common Shares Outstanding
1,0461,0461,0461,0461,0461,046
Working Capital
2,0512,1831,1401,2782,0641,982
Book Value Per Share
4.353.923.853.602.912.46
Tangible Book Value
4,3803,9333,9863,7082,9882,515
Tangible Book Value Per Share
4.193.763.813.552.862.40
Buildings
-386.31383.04372.25342.91342.42
Machinery
-425.35441.06427.9407.9400.23
Construction In Progress
-1.230.526.1834.151.99
Source: S&P Global Market Intelligence. Standard template. Financial Sources.